Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04797767
Title Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

acute myeloid leukemia

myeloid neoplasm

Therapies

Cladribine + Cytarabine + Mitoxantrone + Sargramostim + Venetoclax

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.